DUBUQUE, Iowa (KCRG) - The newest staff member at UnityPoint Health Finley Hospital in Dubuque is helping clean patient rooms ...

The move is the most far-reaching in a series of actions by Health Secretary Robert F. Kennedy Jr., a long-time vaccine ...

RFK Jr. is making good on his promise to radically reshape the vaccine policy landscape as he ousts the entire CDC Advisory ...

Intermountain Health is now offering a national first-of-its kind expansion of CAR-T Cell Therapy, bringing cutting-edge cancer care closer to patients in ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's ...

The artificial sweetener neotame is ubiquitous in popular disposable e-cigarettes, according to a research letter published ...

The American Board of Cosmetic Surgery (ABCS) announced that a new wrinkle-reducing, Botox-type injectable, Letybo ...

Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...

Phathom Pharmaceuticals, Inc. has secured 10 years of FDA exclusivity for Voquezna in GERD, boosting its stock. Click here to ...

The FDA has approved Starjemza (ustekinumab-hmny), a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.